23.09.2020 | Correction
Correction to: Efficacy and safety results from a randomized double-blind study comparing proposed biosimilar ABP 798 with rituximab reference product in subjects with moderate-to-severe rheumatoid arthritis
Erschienen in: Clinical Rheumatology | Ausgabe 11/2020
Einloggen, um Zugang zu erhalten